TY  - JOUR

T1  - Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

JO  - The Lancet

PY  - 2021/09/01

AU  - Flaxman A

AU  - Marchevsky NG

AU  - Jenkin D

AU  - Aboagye J

AU  - Aley PK

AU  - Angus B

AU  - Belij-Rammerstorfer S

AU  - Bibi S

AU  - Bittaye M

AU  - Cappuccini F

AU  - Cicconi P et al

ED  - 

DO  - DOI: 10.1016/s0140-6736(21)01699-8

PB  - Elsevier BV

Y2  - 2024/10/18

ER  -